Atlas Trials

Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies

Clinical trial NCT05966467 · RECRUITING

Trial details

NCT number
NCT05966467
Sponsor
Alexion Pharmaceuticals, Inc.
Status
RECRUITING
Study type
OBSERVATIONAL
Neuromyelitis Optica Spectrum DisorderNMOSDAQP4+ NMOSD
Start date
2024-02-01
Primary completion
2029-09-27
Enrollment
122

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.